LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Replicate Assay Well Timepoint Timepoint Unit Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Relative Growth Rate After Treatment
BT-20 Radicicol
3.33
uM
LJP6
 1
K08
 72
hr
 1657 1785 5505 0.3242 0.0331
BT-20 Radicicol
3.33
uM
LJP6
 2
K08
 72
hr
 1657 1923 5505 0.3493 0.0689
BT-20 Radicicol
3.33
uM
LJP6
 3
K08
 72
hr
 1657 1837 5505 0.3337 0.0466
BT-20 Seliciclib
3.33
uM
LJP5
 1
J02
 72
hr
 1657 4540 5505 0.8246 0.7490
BT-20 Seliciclib
3.33
uM
LJP5
 2
J02
 72
hr
 1657 4469 5505 0.8117 0.7306
BT-20 Seliciclib
3.33
uM
LJP5
 3
J02
 72
hr
 1657 4633 5505 0.8415 0.7732
BT-20 Ruxolitinib
3.33
uM
LJP5
 1
O14
 72
hr
 1657 4753 5505 0.8633 0.8044
BT-20 Ruxolitinib
3.33
uM
LJP5
 2
O14
 72
hr
 1657 4813 5505 0.8742 0.8200
BT-20 Ruxolitinib
3.33
uM
LJP5
 3
O14
 72
hr
 1657 4869 5505 0.8844 0.8345
BT-20 XL147
3.33
uM
LJP5
 1
G08
 72
hr
 1657 4929 5505 0.8953 0.8501
BT-20 XL147
3.33
uM
LJP5
 2
G08
 72
hr
 1657 4729 5505 0.8589 0.7982
BT-20 XL147
3.33
uM
LJP5
 3
G08
 72
hr
 1657 5071 5505 0.9211 0.8870
BT-20 Saracatinib
3.33
uM
LJP6
 1
D08
 72
hr
 1657 3435 5505 0.6239 0.4619
BT-20 Saracatinib
3.33
uM
LJP6
 2
D08
 72
hr
 1657 3471 5505 0.6304 0.4712
BT-20 Saracatinib
3.33
uM
LJP6
 3
D08
 72
hr
 1657 3943 5505 0.7162 0.5939
BT-20 Selumetinib
3.33
uM
LJP6
 1
M08
 72
hr
 1657 5649 5505 1.0260 1.0372
BT-20 Selumetinib
3.33
uM
LJP6
 2
M08
 72
hr
 1657 5878 5505 1.0676 1.0968
BT-20 Selumetinib
3.33
uM
LJP6
 3
M08
 72
hr
 1657 5692 5505 1.0338 1.0484
BT-20 Sirolimus
3.33
uM
LJP6
 1
L14
 72
hr
 1657 3719 5505 0.6755 0.5357
BT-20 Sirolimus
3.33
uM
LJP6
 2
L14
 72
hr
 1657 3960 5505 0.7193 0.5983
BT-20 Sirolimus
3.33
uM
LJP6
 3
L14
 72
hr
 1657 3349 5505 0.6083 0.4395
BT-20 Sorafenib
3.33
uM
LJP6
 1
B08
 72
hr
 1657 4392 5505 0.7977 0.7106
BT-20 Sorafenib
3.33
uM
LJP6
 2
B08
 72
hr
 1657 4512 5505 0.8195 0.7418
BT-20 Sorafenib
3.33
uM
LJP6
 3
B08
 72
hr
 1657 4915 5505 0.8927 0.8465
BT-20 SU11274
3.33
uM
LJP5
 1
J08
 72
hr
 1657 4588 5505 0.8333 0.7615